01788nas a2200229   4500000000100000008004100001260001200042653002900054653003500083653001400118653001600132653004100148653003000189653001600219100001200235245012400247856008600371300000900457490000600466520107200472022001401544       2019                            d  c01/201910aNTD Modelling Consortium10amass drug administration (MDA)10aModelling10aFeasibility10aSustainable Development Goals (SDGs)10aLymphatic filariasis (LF)10aElimination1 aGroup N00aThe roadmap towards elimination of lymphatic filariasis by 2030: insights from quantitative and mathematical modelling.  uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6833911/pdf/gatesopenres-3-14196.pdf  a15380 v33 a<p>The Global Programme to Eliminate Lymphatic Filariasis was launched in 2000 to eliminate lymphatic filariasis (LF) as a public health problem by 1) interrupting transmission through mass drug administration (MDA) and 2) offering basic care to those suffering from lymphoedema or hydrocele due to the infection. Although impressive progress has been made, the initial target year of 2020 will not be met everywhere. The World Health Organization recently proposed 2030 as the new target year for elimination of lymphatic filariasis (LF) as a public health problem. In this letter, LF modelers of the Neglected Tropical Diseases (NTDs) Modelling Consortium reflect on the proposed targets for 2030 from a quantitative perspective. While elimination as a public health problem seems technically and operationally feasible, it is uncertain whether this will eventually also lead to complete elimination of transmission. The risk of resurgence needs to be mitigated by strong surveillance after stopping interventions and sometimes perhaps additional interventions.</p>  a2572-4754